Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

PEN stock hub

Penumbra, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

PENis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
12.7B
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
PEN
In the news

Latest news · PEN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E60.8
P25 12.3P50 18.4P75 33.1
Trailing P/E74.3
P25 14.9P50 23.2P75 38.5
ROE12.7
P25 -105.6P50 -46.5P75 -3.1
ROIC14.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All PEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
250
Groups with data
11
Currency
USD
Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001321732
Company name
Penumbra, Inc.
Country
United States
Country code
US
Cusip
70975L107
Employees
4,700
Employees Change
200%
Employees Change Percent
4.44
Enterprise value
$12.3B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2015-09-18
Isin
US70975L1070
Last refreshed
2026-05-10
Market cap
$12.7B
Market cap category
Large-Cap
Price
$322
Price currency
USD
Rev Per Employee
309,421.91x
Sector
Healthcare
Sic
3841
Symbol
PEN
Website
https://www.penumbrainc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

17
MetricValue
Earnings Yield
1.35%
EV Earnings
71.76x
EV Sales Forward
7.44x
EV/EBIT
65.59x
EV/EBITDA
60.18x
EV/FCF
57.7x
EV/Sales
8.44x
FCF yield
1.68%
Forward P/E
60.76x
P/B ratio
8.6x
P/E ratio
74.28x
P/S ratio
8.71x
PE Ratio10 Y
404.22x
PE Ratio3 Y
229.53x
PE Ratio5 Y
459.17x
PEG ratio
1.89x
PS Forward
7.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
12.87%
EBITDA Margin
14.02%
FCF margin
14.63%
Gross margin
67.38%
Gross Profit
$980M
Gross Profit Growth
19.06%
Gross Profit Growth Q
17.38%
Gross Profit Growth3 Y
20.59%
Gross Profit Growth5 Y
20.87%
Net Income
$171M
Net Income Growth
305.01%
Net Income Growth Q
-16.93%
Net Income Growth Years
1%
Net Income Growth3 Y
197.73%
Pretax Margin
13.96%
Profit Margin
11.76%
Profit Per Employee
$36,393
Profitable Years
3
ROA
6.7
Roa5y
3.13
ROCE
11.09
ROE
12.73
Roe5y
4.69
ROIC
14.49
Roic5y
5.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

18
MetricValue
Cagr10y
19.4%
Cagr1y
11.41%
Cagr3y
1.29%
Cagr5y
3.49%
EPS Growth
302.4
EPS Growth Q
-18
EPS Growth Years
1
EPS Growth3 Y
194
FCF Growth
41.51%
FCF Growth Q
106.46%
OCF Growth
54.43%
OCF Growth Q
77.6%
Revenue Growth
17.27x
Revenue Growth Q
15.62x
Revenue Growth Quarters
23x
Revenue Growth Years
12x
Revenue Growth3 Y
18.02x
Revenue Growth5 Y
19.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
$0.83
Assets
$1.9B
Cash
$615.7M
Current Assets
$1.3B
Current Liabilities
$211.7M
Debt
$216.2M
Debt EBITDA
$0.9
Debt Equity
$0.15
Debt FCF
$1.02
Equity
$1.5B
Interest Coverage
143.3
Liabilities
$424.6M
Long Term Assets
$623M
Long Term Liabilities
$212.9M
Net Cash
$399.5M
Net Cash By Market Cap
$3.15
Net Cash Growth
152.53%
Net Debt EBITDA
$-1.96
Net Debt Equity
$-0.27
Net Debt FCF
$-1.88
Tangible Book Value
$1.3B
Tangible Book Value Per Share
$33.09
WACC
8.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.02
Inventory Turnover
1.11
Net Working Capital
$464.5M
Quick ratio
3.77
Working Capital
$1.1B
Working Capital Turnover
$1.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-0.45%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
488.98%
1Y total return
11.4%
200-day SMA
297.5
3Y total return
3.92%
50-day SMA
332.4
50-day SMA vs 200-day SMA
50over200
5Y total return
18.72%
All Time High
362.4
All Time High Change
-11.09%
All Time High Date
2026-01-21
All Time Low
35.32
All Time Low Change
812.45%
All Time Low Date
2015-10-22
ATR
2.66
Beta
0.74
Beta1y
-0.52
Beta2y
0.08
Ch YTD
3.64
High
324.9
High52
362.4
High52 Date
2026-01-21
High52ch
-11.09%
Low
321.8
Low52
221.3
Low52 Date
2025-11-03
Low52ch
45.63%
Ma50ch
-3.06%
Price vs 200-day SMA
8.3%
RSI
33.61
RSI Monthly
58.43
RSI Weekly
52.2
Sharpe ratio
0.36x
Sortino ratio
0.9
Total Return
-0.45%
Tr YTD
3.64
Tr1m
-2.34%
Tr1w
-0.95%
Tr3m
-5.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

17
MetricValue
Analyst Count
16
Analyst Count Top
1
Analyst Price Target Top
$350
Analyst Ratings
Hold
Analyst Ratings Top
Hold
Earnings EPS Estimate
$1.07
Earnings EPS Estimate Growth
7
Earnings Revenue Estimate
372,021,168x
Earnings Revenue Estimate Growth
14.77x
Operating Income
$187.1M
Operating Income Growth
30.65
Operating Income Growth Q
-5.24
Operating Income Growth3 Y
117.7
Operating margin
12.87
Price target
$357
Price Target Change
$10.68
Price Target Change Top
$8.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
38,136,650%
Float Percent
96.96%
Net Borrowing
-2,489,000
Shares Insiders
2.95%
Shares Institutions
83.85%
Shares Out
39,331,425
Shares Qo Q
0.38%
Shares Yo Y
0.45%
Short Float
5.26%
Short Ratio
3.51
Short Shares
5.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

68
MetricValue
Adjusted FCF
$152.7M
Average Volume
495,033.25x
Bv Per Share
37.48
CAPEX
$-63.9M
Ch10y
489
Ch1m
-2.34
Ch1w
-0.95
Ch1y
11.4
Ch3m
-5.51
Ch3y
3.92
Ch5y
18.72
Ch6m
21.05
Change
-0.75%
Change From Open
-0.82
Close
324.7
Days Gap
0.08
Depreciation Amortization
16,830,000
Dollar Volume
112,802,733.9
Earnings Date
2026-05-06
Earnings Time
amc
EBIT
$187.1M
EBITDA
$204M
EPS
$4.34
F Score
6
FCF
$212.7M
FCF EV Yield
1.73x
FCF Per Share
$5.41
Financing CF
21,917,000
Fiscal Year End
December
Founded
2,004
Goodwill
166,589,000
Graham Number
60.48174
Graham Upside
-81.23
Income Tax
$31.9M
Investing CF
-434,721,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-25
Lynch Fair Value
$108
Lynch Upside
-66.34
Ma150
311.3
Ma150ch
3.5%
Ma20
328.1
Ma20ch
-1.78%
Net CF
-134,765,000
Next Earnings Date
2026-07-28
Open
324.9
Optionable
Yes
P FCF Ratio
59.58
P OCF Ratio
45.81
Position In Range
14.1
Ppne
329,541,000
Price Date
2026-05-08
Price EBITDA
$62.14
Ptbv Ratio
9.74
Relative Volume
0.71x
Revenue
1,454,283,000x
SBC By Revenue
4.13x
Share Based Comp
60,073,000
Tax By Revenue
2.19x
Tax Rate
15.72%
Tr6m
21.05%
Us State
California
Volume
350,069
Z Score
17.63
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does PEN pay a dividend?

Capital-return profile for this ticker.

Performance

PEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+11.4%
S&P 500 1Y: n/a
3Y total return
+3.9%
S&P 500 3Y: n/a
5Y total return
+18.7%
S&P 500 5Y: n/a
10Y total return
+489.0%
S&P 500 10Y: n/a
Ownership

Who owns PEN?

Insider, institutional, and short-interest positioning.

Institutional ownership
+83.9%
Float: +97.0% of shares outstanding
Insider ownership
+3.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+5.3%
3.5 days to cover
Y/Y dilution
+0.4%
Negative means the company is buying back shares.
Technical

PEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
33.6
Neutral momentum band
Price vs 200-day MA
+8.3%
50/200-day relationship not available
Beta (5Y)
0.74
Less volatile than the market
Sharpe ratio
0.36
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About PEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PEN stock rating?

Penumbra, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PEN analysis?

The full report lives at /stocks/PEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PEN?

The latest report frames PEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.